Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
, 18 (1), 34-5

The Clinical Use of Milnacipran for Depression

Affiliations
Clinical Trial

The Clinical Use of Milnacipran for Depression

Shigeru Morishita et al. Eur Psychiatry.

Abstract

We examined the relation between dosage and efficacy, and the predictors of response to milnacipran. There was no difference between 50 and 100 mg dose. However, the 100 mg dose had a faster onset of action than the 50 mg dose. An age and an episode have been predictors of milnacipran.

Similar articles

See all similar articles

Cited by 1 PubMed Central articles

LinkOut - more resources

Feedback